Insider Trading April 20, 2026 05:51 PM

Radian Group General Counsel Disposes of $455k in Stock Under Pre-Set Plan

Senior EVP and general counsel sold 13,009 shares as company posts modest beat in Q4 2025 and trims repurchase facility

By Leila Farooq RDN
Radian Group General Counsel Disposes of $455k in Stock Under Pre-Set Plan
RDN

Edward J. Hoffman, Radian Group Inc.'s senior executive vice president and general counsel, sold 13,009 shares of company common stock on April 17, 2026, in a pre-arranged transaction under a 10b5-1 plan established in December 2025. The shares were sold at $35.00 per share for proceeds of about $455,315. Following the sale, Hoffman retains 138,708 shares. The move coincides with Radian trading at $35.25 and a market capitalization of $4.75 billion, and follows the company reporting slightly stronger-than-expected fourth-quarter 2025 results and reducing a repurchase facility to $25 million.

Key Points

  • Edward J. Hoffman sold 13,009 shares on April 17, 2026, under a 10b5-1 plan established in December 2025, receiving about $455,315.
  • Radian’s Q4 2025 results beat expectations with EPS of $1.16 versus $1.08 forecast and revenue of $301 million versus $300.53 million expected.
  • Radian amended its Master Repurchase Agreement with Everbank Bank, N.A., reducing the maximum borrowing amount to $25 million; the facility finances residential mortgage loans via Radian Mortgage Capital LLC.

Edward J. Hoffman, who serves as senior executive vice president and general counsel at Radian Group Inc. (NYSE:RDN), executed a sale of 13,009 shares of Radian common stock on April 17, 2026. The shares were sold at $35.00 each, producing gross proceeds of approximately $455,315.

The transaction was carried out under a pre-established 10b5-1 trading plan that Hoffman put in place in December 2025. After the disposition, Hoffman directly holds 138,708 shares of Radian common stock.

At the time of the sale, Radian shares were trading at $35.25 and the company had a market capitalization of $4.75 billion. According to an InvestingPro analysis cited in company reporting, the stock appears undervalued at current levels and the company maintains a price-to-earnings ratio of 8.03. The InvestingPro note also references that subscribers have access to over five additional tips for RDN, including data on the company’s six consecutive years of dividend increases.

Separately, Radian reported quarterly results for the fourth quarter of 2025 that were stronger than expectations. The company posted earnings per share of $1.16, outpacing analyst estimates of $1.08 by 7.41%. Revenue for the quarter came in at $301 million, slightly above the forecasted $300.53 million.

Radian also amended its Master Repurchase Agreement with Everbank Bank, N.A., through a second amendment that reduced the maximum borrowing amount under the facility to $25 million. The repurchase facility is used by Radian Mortgage Capital LLC, a subsidiary of Radian Group, to finance residential mortgage loans. Those loans are either sold directly to mortgage investors or placed into the capital markets through securitization.

The sale by Hoffman and the corporate updates provide concurrent snapshots of insider activity, recent financial performance and adjustments to short-term financing arrangements. The 10b5-1 plan governing Hoffman’s sale indicates the transaction was executed according to a prior arrangement established in December 2025.


Key details

  • Insider transaction: 13,009 shares sold at $35.00 per share on April 17, 2026, totaling roughly $455,315.
  • Post-transaction holdings: Hoffman directly holds 138,708 shares.
  • Company context: Radian trading at $35.25 with a market cap of $4.75 billion; P/E ratio 8.03 per InvestingPro analysis.

Risks

  • Changes to the repurchase agreement reduce the maximum borrowing capacity to $25 million, which could affect financing for residential mortgage loans funded by Radian Mortgage Capital LLC - relevant to mortgage finance and capital markets.
  • Insider selling, even when executed under a 10b5-1 plan, can introduce uncertainty around insider holdings and market perception of the stock - relevant to equity markets and investor sentiment.
  • Valuation differences exist as InvestingPro analysis indicates the stock appears undervalued with a P/E of 8.03, but such assessments may vary among analysts and investors - relevant to financials sector valuation debates.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026